Annual CFI
$39.26 M
+$45.97 M+685.48%
December 31, 2024
Summary
- As of March 12, 2025, AUPH annual cash flow from investing activities is $39.26 million, with the most recent change of +$45.97 million (+685.48%) on December 31, 2024.
- During the last 3 years, AUPH annual CFI has risen by +$143.13 million (+137.80%).
- AUPH annual CFI is now at all-time high.
Performance
AUPH Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$39.22 M
+$49.80 M+471.01%
December 31, 2024
Summary
- As of March 12, 2025, AUPH quarterly cash flow from investing activities is $39.22 million, with the most recent change of +$49.80 million (+471.01%) on December 31, 2024.
- Over the past year, AUPH quarterly CFI has stayed the same.
- AUPH quarterly CFI is now -54.89% below its all-time high of $86.96 million, reached on December 31, 2017.
Performance
AUPH Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$39.26 M
+$45.48 M+731.42%
December 31, 2024
Summary
- As of March 12, 2025, AUPH TTM cash flow from investing activities is $39.26 million, with the most recent change of +$45.48 million (+731.42%) on December 31, 2024.
- Over the past year, AUPH TTM CFI has stayed the same.
- AUPH TTM CFI is now -44.56% below its all-time high of $70.82 million, reached on September 30, 2018.
Performance
AUPH TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AUPH Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +685.5% | 0.0% | 0.0% |
| 3 y3 years | +137.8% | +178.1% | +162.2% |
| 5 y5 years | +404.5% | +178.1% | +162.2% |
AUPH Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +137.8% | -20.3% | +174.0% | at high | +137.8% |
| 5 y | 5-year | at high | +124.8% | -20.3% | +127.1% | at high | +118.4% |
| alltime | all time | at high | +124.8% | -54.9% | +127.1% | -44.6% | +118.4% |
Aurinia Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $39.26 M(-685.5%) | $39.22 M(-471.0%) | $39.26 M(-731.4%) |
| Sep 2024 | - | -$10.57 M(-72.6%) | -$6.22 M(-59.5%) |
| Jun 2024 | - | -$38.62 M(-178.4%) | -$15.35 M(-186.9%) |
| Mar 2024 | - | $49.23 M(-886.8%) | $17.67 M(-363.5%) |
| Dec 2023 | -$6.71 M(-88.9%) | -$6.26 M(-68.2%) | -$6.71 M(+93.4%) |
| Sep 2023 | - | -$19.70 M(+251.3%) | -$3.47 M(-89.8%) |
| Jun 2023 | - | -$5.61 M(-122.6%) | -$33.98 M(-297.1%) |
| Mar 2023 | - | $24.86 M(-923.7%) | $17.25 M(-128.4%) |
| Dec 2022 | -$60.63 M(-41.6%) | -$3.02 M(-94.0%) | -$60.63 M(-3.9%) |
| Sep 2022 | - | -$50.22 M(-210.1%) | -$63.10 M(+38.1%) |
| Jun 2022 | - | $45.62 M(-186.0%) | -$45.69 M(-49.0%) |
| Mar 2022 | - | -$53.02 M(+866.2%) | -$89.64 M(-13.7%) |
| Dec 2021 | -$103.87 M(-34.3%) | -$5.49 M(-83.3%) | -$103.87 M(+31.1%) |
| Sep 2021 | - | -$32.81 M(-2064.4%) | -$79.24 M(-58.5%) |
| Jun 2021 | - | $1.67 M(-102.5%) | -$190.93 M(-10.5%) |
| Mar 2021 | - | -$67.25 M(-451.2%) | -$213.31 M(+34.8%) |
| Dec 2020 | -$158.19 M(-2132.5%) | $19.15 M(-113.3%) | -$158.19 M(-10.8%) |
| Sep 2020 | - | -$144.50 M(+597.7%) | -$177.36 M(+439.2%) |
| Jun 2020 | - | -$20.71 M(+70.8%) | -$32.89 M(+299.5%) |
| Mar 2020 | - | -$12.13 M(>+9900.0%) | -$8.23 M(-205.8%) |
| Dec 2019 | $7.78 M(<-9900.0%) | -$29.00 K(-3.3%) | $7.78 M(-67.4%) |
| Sep 2019 | - | -$30.00 K(-100.8%) | $23.88 M(+34.0%) |
| Jun 2019 | - | $3.95 M(+1.6%) | $17.83 M(-25.2%) |
| Mar 2019 | - | $3.89 M(-75.8%) | $23.85 M(<-9900.0%) |
| Dec 2018 | -$65.00 K(-99.2%) | $16.07 M(-364.1%) | -$65.00 K(-100.1%) |
| Sep 2018 | - | -$6.08 M(-161.0%) | $70.82 M(-987.3%) |
| Jun 2018 | - | $9.97 M(-149.8%) | -$7.98 M(-68.0%) |
| Mar 2018 | - | -$20.02 M(-123.0%) | -$24.98 M(+212.1%) |
| Dec 2017 | -$8.00 M(-180.1%) | $86.96 M(-202.4%) | -$8.00 M(-91.3%) |
| Sep 2017 | - | -$84.89 M(+1108.4%) | -$91.93 M(+1199.1%) |
| Jun 2017 | - | -$7.03 M(+130.5%) | -$7.08 M(-277.5%) |
| Mar 2017 | - | -$3.05 M(-200.4%) | $3.99 M(-60.1%) |
| Dec 2016 | $9.99 M(<-9900.0%) | $3.04 M(-7884.6%) | $9.99 M(+43.7%) |
| Sep 2016 | - | -$39.00 K(-101.0%) | $6.96 M(-0.8%) |
| Jun 2016 | - | $4.04 M(+36.6%) | $7.01 M(+138.2%) |
| Mar 2016 | - | $2.96 M(>+9900.0%) | $2.94 M(<-9900.0%) |
| Dec 2015 | -$23.00 K(-99.8%) | $0.00(-100.0%) | -$23.00 K(-46.5%) |
| Sep 2015 | - | $19.00 K(-161.3%) | -$43.00 K(-99.6%) |
| Jun 2015 | - | -$31.00 K(+181.8%) | -$10.07 M(-0.2%) |
| Mar 2015 | - | -$11.00 K(-45.0%) | -$10.09 M(+0.1%) |
| Dec 2014 | -$10.08 M(>+9900.0%) | -$20.00 K(-99.8%) | -$10.08 M(+0.0%) |
| Sep 2014 | - | -$10.01 M(>+9900.0%) | -$10.08 M(>+9900.0%) |
| Jun 2014 | - | -$47.00 K(<-9900.0%) | -$96.00 K(0.0%) |
| Mar 2014 | - | $0.00(-100.0%) | -$96.00 K(+166.7%) |
| Dec 2013 | -$36.00 K(+15.4%) | -$19.00 K(-36.7%) | -$36.00 K(+34.3%) |
| Sep 2013 | - | -$30.00 K(-36.2%) | -$26.80 K(+6600.0%) |
| Jun 2013 | - | -$47.00 K(-178.3%) | -$400.00(-100.0%) |
| Mar 2013 | - | $60.00 K(-712.2%) | $888.90 K(-2958.2%) |
| Dec 2012 | -$31.20 K(-97.3%) | -$9800.00(+172.2%) | -$31.10 K(-70.7%) |
| Sep 2012 | - | -$3600.00(-100.4%) | -$106.30 K(+115.6%) |
| Jun 2012 | - | $842.30 K(-197.9%) | -$49.30 K(-94.6%) |
| Mar 2012 | - | -$860.00 K(+911.8%) | -$920.20 K(-20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$1.15 M(-166.3%) | -$85.00 K(-259.2%) | -$1.15 M(+11.8%) |
| Sep 2011 | - | $53.40 K(-286.7%) | -$1.03 M(-4.1%) |
| Jun 2011 | - | -$28.60 K(-97.4%) | -$1.07 M(-4.3%) |
| Mar 2011 | - | -$1.09 M(-3071.7%) | -$1.12 M(-164.6%) |
| Dec 2010 | $1.74 M(-1162.9%) | $36.70 K(+290.4%) | $1.74 M(+5.4%) |
| Sep 2010 | - | $9400.00(-112.2%) | $1.65 M(+8.0%) |
| Jun 2010 | - | -$77.10 K(-104.4%) | $1.52 M(-70.3%) |
| Mar 2010 | - | $1.77 M(-3497.5%) | $5.14 M(-3246.3%) |
| Dec 2009 | -$163.30 K(-51.0%) | -$52.00 K(-54.0%) | -$163.40 K(-22.4%) |
| Sep 2009 | - | -$113.10 K(-103.2%) | -$210.70 K(+35.1%) |
| Jun 2009 | - | $3.54 M(-200.0%) | -$156.00 K(-95.9%) |
| Mar 2009 | - | -$3.54 M(+3462.6%) | -$3.80 M(+1038.0%) |
| Dec 2008 | -$333.60 K(-103.6%) | -$99.30 K(+70.0%) | -$333.60 K(-111.7%) |
| Sep 2008 | - | -$58.40 K(-42.2%) | $2.85 M(-39.7%) |
| Jun 2008 | - | -$101.10 K(+35.2%) | $4.73 M(-33.8%) |
| Mar 2008 | - | -$74.80 K(-102.4%) | $7.14 M(-22.7%) |
| Dec 2007 | $9.23 M(-51.5%) | $3.09 M(+69.7%) | $9.23 M(-9.6%) |
| Sep 2007 | - | $1.82 M(-21.2%) | $10.21 M(-26.9%) |
| Jun 2007 | - | $2.31 M(+14.4%) | $13.96 M(-14.6%) |
| Mar 2007 | - | $2.02 M(-50.3%) | $16.36 M(-14.0%) |
| Dec 2006 | $19.02 M(+159.5%) | $4.06 M(-27.1%) | $19.02 M(+9.5%) |
| Sep 2006 | - | $5.57 M(+18.5%) | $17.37 M(+90.7%) |
| Jun 2006 | - | $4.70 M(+0.4%) | $9.11 M(+23.5%) |
| Mar 2006 | - | $4.68 M(+94.5%) | $7.38 M(+0.6%) |
| Dec 2005 | $7.33 M(+648.1%) | $2.41 M(-189.7%) | $7.33 M(+91.5%) |
| Sep 2005 | - | -$2.68 M(-190.3%) | $3.83 M(+30.2%) |
| Jun 2005 | - | $2.97 M(-35.9%) | $2.94 M(-66.4%) |
| Mar 2005 | - | $4.64 M(-523.0%) | $8.75 M(+793.1%) |
| Dec 2004 | $979.90 K(-106.8%) | -$1.10 M(-69.3%) | $979.90 K(-108.6%) |
| Sep 2004 | - | -$3.57 M(-140.7%) | -$11.43 M(+53.6%) |
| Jun 2004 | - | $8.78 M(-380.1%) | -$7.44 M(-56.7%) |
| Mar 2004 | - | -$3.14 M(-76.8%) | -$17.20 M(+19.3%) |
| Dec 2003 | -$14.41 M(-36.1%) | -$13.51 M(-3332.7%) | -$14.41 M(-15.6%) |
| Sep 2003 | - | $417.80 K(-142.7%) | -$17.08 M(-21.4%) |
| Jun 2003 | - | -$978.40 K(+182.1%) | -$21.72 M(+2.4%) |
| Mar 2003 | - | -$346.80 K(-97.9%) | -$21.22 M(-5.8%) |
| Dec 2002 | -$22.54 M(-998.8%) | -$16.17 M(+282.9%) | -$22.54 M(+254.0%) |
| Sep 2002 | - | -$4.22 M(+781.7%) | -$6.37 M(-1.5%) |
| Jun 2002 | - | -$479.10 K(-71.2%) | -$6.46 M(+3.7%) |
| Mar 2002 | - | -$1.66 M(-61.5%) | -$6.23 M(-45.9%) |
| Dec 2001 | $2.51 M(-134.6%) | - | - |
| Aug 2001 | - | -$4.32 M(+1634.9%) | -$11.53 M(+59.5%) |
| May 2001 | - | -$249.00 K(+98.2%) | -$7.23 M(-0.2%) |
| Feb 2001 | - | -$125.60 K(-98.2%) | -$7.24 M(-0.2%) |
| Nov 2000 | -$7.25 M(+5240.8%) | -$6.84 M(>+9900.0%) | -$7.25 M(+1631.8%) |
| Aug 2000 | - | -$16.40 K(-93.8%) | -$418.80 K(-21.9%) |
| May 2000 | - | -$262.60 K(+90.6%) | -$536.20 K(+96.0%) |
| Feb 2000 | - | -$137.80 K(+6790.0%) | -$273.60 K(+101.5%) |
| Nov 1999 | -$135.80 K(+108.6%) | -$2000.00(-98.5%) | -$135.80 K(+1.5%) |
| Aug 1999 | - | -$133.80 K(<-9900.0%) | -$133.80 K(<-9900.0%) |
| May 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Feb 1999 | - | $0.00 | $0.00 |
| Nov 1998 | -$65.10 K | - | - |
FAQ
- What is Aurinia Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual CFI year-on-year change?
- What is Aurinia Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly CFI year-on-year change?
- What is Aurinia Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals TTM CFI year-on-year change?
What is Aurinia Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of AUPH is $39.26 M
What is the all time high annual CFI for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual cash flow from investing activities is $39.26 M
What is Aurinia Pharmaceuticals annual CFI year-on-year change?
Over the past year, AUPH annual cash flow from investing activities has changed by +$45.97 M (+685.48%)
What is Aurinia Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of AUPH is $39.22 M
What is the all time high quarterly CFI for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly cash flow from investing activities is $86.96 M
What is Aurinia Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, AUPH quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Aurinia Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of AUPH is $39.26 M
What is the all time high TTM CFI for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high TTM cash flow from investing activities is $70.82 M
What is Aurinia Pharmaceuticals TTM CFI year-on-year change?
Over the past year, AUPH TTM cash flow from investing activities has changed by $0.00 (0.00%)